Background Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis,
which are typically transmitted via respiratory droplets, are leading causes of invasive …

Background A novel multicomponent vaccine against meningococcal capsular group B (MenB)
disease contains four major components: factor-H-binding protein, neisserial heparin …

Background Recombinant forms of Neisseria meningitidis human factor H binding protein (fHBP)
are undergoing clinical trials in candidate vaccines against invasive meningococcal …

The initial attachment of Neisseria meningitidis to the target cell surface appears to be largely
pilus depend‐ent in capsulated bacteria. Intimate adhesion subsequently occurs to permit …

Background The Invasive Respiratory Infection Surveillance (IRIS) Consortium was
established to assess the impact of the COVID-19 pandemic on invasive diseases caused by …

Bacteria have developed several mechanisms which allow the preferred utilization of the
most efficiently metabolizable carbohydrates when these organisms are exposed to a mixture …

Innate lymphoid cells (ILCs) are involved in immune responses to microbes and various
stressed cells, such as tumor cells. They include group 1 [such as natural killer (NK) cells and …

A new vaccine, 4CMenB, is composed of surface proteins of Neisseria meningitidis and is
aimed to target serogroup B (MenB) isolates. The vaccine components are present in …

Background Outer-membrane-vesicle vaccines for meningococcal B outbreaks are complex
and time consuming to develop. We studied the use of already available vaccine to control …

Phagosomes containing M. tuberculosis and M. bovis BCG interact normally with early
endosomes but fail to fuse with late endosomes and lysosomes. Whereas many early events of …